| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 453,443 | 581,345 | 697,942 | 253,019 |
| Restricted cash | 0 | 0 | 783 | 783 |
| Accounts receivable | - | - | 1,018 | 6,244 |
| Digital assets | 241,355 | 172,772 | 80,646 | 0 |
| Prepaid expenses and other current assets | - | - | 52,789 | 17,810 |
| Customer funding receivable and other current assets | 366,235 | 250,643 | - | - |
| Total current assets | 1,061,033 | 1,004,760 | 833,178 | 277,856 |
| Property, plant and equipment, net | 1,078,803 | 828,603 | 650,291 | 550,432 |
| Operating lease right-of-use assets | 107,784 | 108,584 | 111,203 | 74,733 |
| Other noncurrent assets | 48,360 | 36,105 | 30,699 | 18,830 |
| Total assets | 2,295,980 | 1,978,052 | 1,625,371 | 921,851 |
| Accounts payable | 212,179 | 215,055 | 6,328 | 6,504 |
| Accrued expenses | 358,270 | 180,641 | 95,492 | 31,726 |
| Deferred revenue | 83,739 | 150,127 | 60,872 | 9,944 |
| Operating lease liabilities, current portion | - | - | 9,982 | 7,486 |
| Finance lease liabilities, current portion | - | - | 1,161 | 2,380 |
| Notes payable, current portion | - | - | 16,214 | 17,941 |
| Contingent value rights, current portion | - | - | 5,461 | 533 |
| Other current liabilities | 15,675 | 16,899 | - | - |
| Total current liabilities | 669,863 | 562,722 | 195,510 | 76,514 |
| Operating lease liabilities, net of current portion | - | - | 94,953 | 65,335 |
| Finance lease liabilities, net of current portion | - | - | - | 4 |
| Convertible and other notes payable, net of current portion | 1,059,007 | 1,057,696 | 1,071,843 | 474,596 |
| Contingent value rights, net of current portion | - | - | 11,628 | 6,458 |
| Warrant liabilities | 1,330,483 | 1,316,690 | 421,902 | 1,017,299 |
| Other noncurrent liabilities | 364,587 | 105,620 | 11,042 | 11,040 |
| Total liabilities not subject to compromise | - | - | - | 1,651,246 |
| Liabilities subject to compromise | - | - | - | 0 |
| Total liabilities | 3,423,940 | 3,042,728 | 1,806,878 | 1,651,246 |
| Common stock 0.00001 par value 10,000,000 shares authorized at september30, 2025 and december31, 2024 308,381 and 292,606 shares issued and outstanding at september30, 2025 and december31, 2024, respectively | 3 | 3 | 3 | 3 |
| Additionalpaid-incapital | 3,110,021 | 3,026,645 | 2,973,015 | 2,740,279 |
| Accumulated deficit | -4,237,984 | -4,091,324 | -3,154,525 | -3,469,677 |
| Total stockholders deficit | -1,127,960 | -1,064,676 | -181,507 | -729,395 |
| Total liabilities and stockholders deficit | 2,295,980 | 1,978,052 | 1,625,371 | 921,851 |
Core Scientific, Inc. tx (CORZR)
Core Scientific, Inc. tx (CORZR)